Drug profile · INN
irbesartan: hydrochlorothiazide
IRBESARTAN; HYDROCHLOROTHIAZIDE
irbesartan: hydrochlorothiazide (IRBESARTAN; HYDROCHLOROTHIAZIDE) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Drug details — irbesartan: hydrochlorothiazide
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
irbesartan: hydrochlorothiazide (IRBESARTAN; HYDROCHLOROTHIAZIDE) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Frequently asked questions
What is irbesartan: hydrochlorothiazide?
irbesartan: hydrochlorothiazide (IRBESARTAN; HYDROCHLOROTHIAZIDE) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for irbesartan: hydrochlorothiazide?
IRBESARTAN; HYDROCHLOROTHIAZIDE is a marketed brand name for irbesartan: hydrochlorothiazide. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of irbesartan: hydrochlorothiazide?
irbesartan: hydrochlorothiazide has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.